Negócios · 22/11/20051 min de leitura
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Regulations For In Vivo Radiopharmaceuticals Used For Diagnosis and Monitoring" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.